Literature DB >> 17024563

Programmed death-1 gene polymorphisms in patients with systemic lupus erythematosus in Taiwan.

Shu-Chen Wang1, Yi-Jing Chen, Tsan-Teng Ou, Cheng-Chin Wu, Wen-Chan Tsai, Hong-Wen Liu, Jeng-Hsien Yen.   

Abstract

To investigate the role of programmed cell death-1 (PD-1) gene polymorphisms in the development of systemic lupus erythematosus (SLE) in Taiwan, 109 patients with SLE and 100 healthy controls were enrolled in this study. The PD-1 gene polymorphisms were determined by the method of polymerase chain reaction/restriction fragment length polymorphism. This study showed that the genotype distributions of PD-1 7209 C/T polymorphisms were significantly different between the patients with SLE and controls (P=0.002, Pc=0.018). The frequencies of the PD-1 7209 C/C genotype and PD-1 7209 C allele were significantly higher in the patients with SLE than those of the controls (P=0.001, OR=2.6, 95% CI=1.5-4.6, and P=0.002, OR=2.1, 95% CI=1.3-3.4, Pc=0.018, respectively). Moreover, the association of PD-1 7209 C with susceptibility to SLE was independent of the PD-1 ligand. This study also showed that the PD-1-536 A 7146 G 7209 C 7499 G haplotype was associated with the development of SLE in Taiwan.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024563     DOI: 10.1007/s10875-006-9048-9

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  27 in total

1.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.

Authors:  T Okazaki; A Maeda; H Nishimura; T Kurosaki; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

2.  Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus.

Authors:  V Magnusson; A K Lindqvist; C Castillejo-López; H Kristjánsdottir; K Steinsson; G Gröndal; G Sturfelt; L Truedsson; E Svenungsson; I Lundberg; I Gunnarsson; A I Bolstad; H J Haga; R Jonsson; L Klareskog; J Alcocer-Varela; D Alarcón-Segovia; J D Terwilliger; U B Gyllensten; M E Alarcón-Riquelme
Journal:  Genomics       Date:  2000-12-15       Impact factor: 5.736

3.  Expression of chimeric monomer and dimer proteins on the plasma membrane of mammalian cells.

Authors:  W C Chou; K W Liao; Y C Lo; S Y Jiang; M Y Yeh; S R Roffler
Journal:  Biotechnol Bioeng       Date:  1999-10-20       Impact factor: 4.530

4.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice.

Authors:  H Nishimura; T Okazaki; Y Tanaka; K Nakatani; M Hara; A Matsumori; S Sasayama; A Mizoguchi; H Hiai; N Minato; T Honjo
Journal:  Science       Date:  2001-01-12       Impact factor: 47.728

5.  Transmembrane domain-induced oligomerization is crucial for the functions of syndecan-2 and syndecan-4.

Authors:  Sungmun Choi; Eunjung Lee; Soojin Kwon; Haein Park; Jae Youn Yi; Seungin Kim; Inn-Oc Han; Yungdae Yun; Eok-Soo Oh
Journal:  J Biol Chem       Date:  2005-10-27       Impact factor: 5.157

Review 6.  Update on human systemic lupus erythematosus genetics.

Authors:  Betty P Tsao
Journal:  Curr Opin Rheumatol       Date:  2004-09       Impact factor: 5.006

7.  Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.

Authors:  Ludmila Prokunina; Leonid Padyukov; Anna Bennet; Ulf de Faire; Björn Wiman; Jonathan Prince; Lars Alfredsson; Lars Klareskog; Marta Alarcón-Riquelme
Journal:  Arthritis Rheum       Date:  2004-06

8.  Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus.

Authors:  Shih-Chang Lin; Jeng-Hsien Yen; Jaw-Ji Tsai; Wen-Chen Tsai; Tsan-Teng Ou; Hong-Wen Liu; Chung-Jen Chen
Journal:  Arthritis Rheum       Date:  2004-03

9.  Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes.

Authors:  C Nielsen; D Hansen; S Husby; B B Jacobsen; S T Lillevang
Journal:  Tissue Antigens       Date:  2003-12

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  18 in total

Review 1.  PD-1, gender, and autoimmunity.

Authors:  Ravi K Dinesh; Bevra H Hahn; Ram Pyare Singh
Journal:  Autoimmun Rev       Date:  2010-04-28       Impact factor: 9.754

2.  Polymorphisms in programmed death-1 gene are not associated with chronic HBV infection in Chinese patients.

Authors:  Feng Lv; Yu-Feng Gao; Zhen-Huan Zhang; Tian-Chen Zhang; Fa-Ming Pan; Ming-Fang Cui; Shu-Ling Xia; Xu Li; Hua-Fa Yin
Journal:  World J Hepatol       Date:  2011-03-27

3.  Program death 1 (PD1) haplotyping in patients with breast carcinoma.

Authors:  Mohammad Reza Haghshenas; Sirous Naeimi; Abdolrasoul Talei; Abbas Ghaderi; Nasrollah Erfani
Journal:  Mol Biol Rep       Date:  2010-11-27       Impact factor: 2.316

4.  Association between hepatitis B viral burden in chronic infection and a functional single nucleotide polymorphism of the PDCD1 gene.

Authors:  Linghua Zheng; Dongling Li; Fusheng Wang; Hao Wu; Xiaozhu Li; Junliang Fu; Xinyue Chen; Lizhong Wang; Yang Liu; Shengdian Wang
Journal:  J Clin Immunol       Date:  2010-08-11       Impact factor: 8.317

5.  Inverse correlation of programmed death 1 (PD-1) expression in T cells to the spinal radiologic changes in Taiwanese patients with ankylosing spondylitis.

Authors:  Ming-Han Chen; Wei-Sheng Chen; Hui-Ting Lee; Chang-Youh Tsai; Chung-Tei Chou
Journal:  Clin Rheumatol       Date:  2011-03-10       Impact factor: 2.980

6.  Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population.

Authors:  Xiang Liu; Li-Hua Hu; Yi-Rong Li; Feng-Hua Chen; Yong Ning; Qun-Feng Yao
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

7.  Polymorphisms of genes for programmed cell death 1 ligands in patients with rheumatoid arthritis.

Authors:  Shu-Chen Wang; Chia-Hui Lin; Ruei-Nian Li; Tsan-Teng Ou; Cheng-Chin Wu; Wen-Chan Tsai; Hong-Wen Liu; Jeng-Hsien Yen
Journal:  J Clin Immunol       Date:  2007-06-28       Impact factor: 8.317

8.  Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1.

Authors:  N Mozaffarian; A E Wiedeman; A M Stevens
Journal:  Rheumatology (Oxford)       Date:  2008-07-23       Impact factor: 7.580

9.  Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki Disease.

Authors:  Jin-Kyong Chun; Dong Won Kang; Byung Won Yoo; Jeon-Soo Shin; Dong Soo Kim
Journal:  Eur J Pediatr       Date:  2009-05-26       Impact factor: 3.183

Review 10.  Coinhibitory molecules in autoimmune diseases.

Authors:  Norihiko Watanabe; Hiroshi Nakajima
Journal:  Clin Dev Immunol       Date:  2012-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.